Konruns(SH:603590) Zheng Xing Xing Ye Ri Bao·2025-09-10 08:30Market Overview - The biopharmaceutical sector experienced a decline of 0.7% on September 10, with Kangchen Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - Baipusais (301080) with a closing price of 60.80, up 7.04% [1] - Aopumai (688293) with a closing price of 52.54, up 3.02% [1] - ST Weiming (002581) with a closing price of 7.83, up 1.56% [1] - Significant decliners included: - Kangchen Pharmaceutical (603590) with a closing price of 52.17, down 5.06% [2] - Wo Wu Biological (300357) with a closing price of 31.59, down 4.45% [2] - Aidi Pharmaceutical (688488) with a closing price of 15.68, down 3.80% [2] Capital Flow - The biopharmaceutical sector saw a net outflow of 444 million yuan from institutional investors, while retail investors contributed a net inflow of 269 million yuan [2] - The capital flow for individual stocks showed: - Kangtai Biological (300601) had a net inflow of 31.13 million yuan from institutional investors [3] - Junshi Biological (688180) experienced a net outflow of 12.11 million yuan from retail investors [3] - Wanzhe Co. (000534) had a net inflow of 14.46 million yuan from institutional investors [3]